Literature DB >> 6415785

Toxins of Pseudomonas aeruginosa: new perspectives.

D E Woods, B H Iglewski.   

Abstract

Toxin A is a protein with a molecular mass of approximately 66,000 daltons whose production is regulated by iron. The toxicity of toxin A is due to its ability to inhibit protein synthesis. A role for toxin A in infections due to Pseudomonas aeruginosa is supported by its extreme toxicity, its production by most clinical isolates, the decreased virulence of nontoxic mutants, and the results of immunologic studies of animals and humans.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6415785     DOI: 10.1093/clinids/5.supplement_4.s715

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  28 in total

1.  Transient aberrancy of alpha 1-antitrypsin glycoprotein microheterogeneity in Pseudomonas aeruginosa septicaemia.

Authors:  K Heyne; S Weidinger
Journal:  Infection       Date:  1990 Nov-Dec       Impact factor: 3.553

2.  Cloning and sequence analysis of a trans-regulatory locus required for exoenzyme S synthesis in Pseudomonas aeruginosa.

Authors:  D W Frank; B H Iglewski
Journal:  J Bacteriol       Date:  1991-10       Impact factor: 3.490

3.  Specific cleavage of human type III and IV collagens by Pseudomonas aeruginosa elastase.

Authors:  L W Heck; K Morihara; W B McRae; E J Miller
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

4.  The investigation of bacteriology of chronic suppurative otitis media in patients attending a tertiary care hospital with special emphasis on seasonal variation.

Authors:  P K Maji; T K Chatterjee; S Chatterjee; J Chakrabarty; B B Mukhopadhyay
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2007-09-14

5.  Pseudomonas aeruginosa lipopolysaccharide binds galectin-3 and other human corneal epithelial proteins.

Authors:  S K Gupta; S Masinick; M Garrett; L D Hazlett
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

6.  Pseudomonas aeruginosa immunotype 5 polysaccharide-toxin A conjugate vaccine.

Authors:  S J Cryz; E Furer; J C Sadoff; R Germanier
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

7.  Characterization of antibody to the ferripyochelin-binding protein of Pseudomonas aeruginosa.

Authors:  P A Sokol; D E Woods
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

8.  Genetic mapping and characterization of Pseudomonas aeruginosa mutants that hyperproduce exoproteins.

Authors:  A Björklind; B Wretlind; I Möllegård; P A Schad; B H Iglewski; C D Cox
Journal:  J Bacteriol       Date:  1985-06       Impact factor: 3.490

Review 9.  New insights into the epidemiology, pathogenesis and therapy of Pseudomonas aeruginosa infections.

Authors:  S J Cryz
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

10.  Expression of recombinant exoenzyme S of Pseudomonas aeruginosa.

Authors:  S M Kulich; D W Frank; J T Barbieri
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.